NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Rheumatoid Arthritis
Date of first enrollment	01/12/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : T-5224 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Oral administration control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral administration

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome	Efficacy and safety

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 64age old
Gender	Both
Include criteria	-Male or female. -Subject who have a diagnosis of Rheumatoid Arthritis by the ACR criteria. -Age greater or 20 years and less than 65 years old. -Subject who diagnosed to class 1-3 of Steinblocker dysfunction classification.
Exclude criteria	-Subject with autoimmune disease except RA and SS. -Subject who is pregnancy, has possibility of pregnancy, hopes for pregnancy, is suckling.